Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)

BACKGROUND: Chemotherapy remains a viable option for the management of advanced non-small-cell lung cancer (NSCLC) despite recent advances in molecular targeted therapy and immunotherapy. We evaluated the efficacy of oral 5-fluorouracil-based S-1 as second- or third-line therapy compared with standa...

Descripción completa

Detalles Bibliográficos
Autores principales: Nokihara, H, Lu, S, Mok, T S K, Nakagawa, K, Yamamoto, N, Shi, Y K, Zhang, L, Soo, R A, Yang, J C, Sugawara, S, Nishio, M, Takahashi, T, Goto, K, Chang, J, Maemondo, M, Ichinose, Y, Cheng, Y, Lim, W T, Morita, S, Tamura, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834128/
https://www.ncbi.nlm.nih.gov/pubmed/29045553
http://dx.doi.org/10.1093/annonc/mdx419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834128/
https://www.ncbi.nlm.nih.gov/pubmed/29045553
http://dx.doi.org/10.1093/annonc/mdx419

Ejemplares similares